These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36294819)

  • 1. Adipogenic Signaling Promotes Arrhythmia Substrates before Structural Abnormalities in TMEM43 ARVC.
    Vasireddi SK; Sattayaprasert P; Yang D; Dennis AT; Bektik E; Fu JD; Mackall JA; Laurita KR
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
    Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
    Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations.
    Baskin B; Skinner JR; Sanatani S; Terespolsky D; Krahn AD; Ray PN; Scherer SW; Hamilton RM
    Hum Genet; 2013 Nov; 132(11):1245-52. PubMed ID: 23812740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy.
    Rajkumar R; Sembrat JC; McDonough B; Seidman CE; Ahmad F
    BMC Med Genet; 2012 Mar; 13():21. PubMed ID: 22458570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating arrhythmogenic right ventricular cardiomyopathy with stem cells.
    Laurita KR; Vasireddi SK; Mackall JA
    Birth Defects Res; 2022 Oct; 114(16):948-958. PubMed ID: 35396927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.
    Dominguez F; Zorio E; Jimenez-Jaimez J; Salguero-Bodes R; Zwart R; Gonzalez-Lopez E; Molina P; Bermúdez-Jiménez F; Delgado JF; Braza-Boïls A; Bornstein B; Toquero J; Segovia J; Van Tintelen JP; Lara-Pezzi E; Garcia-Pavia P
    Heart Rhythm; 2020 Jun; 17(6):945-954. PubMed ID: 32062046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM43 mutation p.S358L alters intercalated disc protein expression and reduces conduction velocity in arrhythmogenic right ventricular cardiomyopathy.
    Siragam V; Cui X; Masse S; Ackerley C; Aafaqi S; Strandberg L; Tropak M; Fridman MD; Nanthakumar K; Liu J; Sun Y; Su B; Wang C; Liu X; Yan Y; Mendlowitz A; Hamilton RM
    PLoS One; 2014; 9(10):e109128. PubMed ID: 25343256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus.
    Milting H; Klauke B; Christensen AH; Müsebeck J; Walhorn V; Grannemann S; Münnich T; Šarić T; Rasmussen TB; Jensen HK; Mogensen J; Baecker C; Romaker E; Laser KT; zu Knyphausen E; Kassner A; Gummert J; Judge DP; Connors S; Hodgkinson K; Young TL; van der Zwaag PA; van Tintelen JP; Anselmetti D
    Eur Heart J; 2015 Apr; 36(14):872-81. PubMed ID: 24598986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells.
    Lombardi R; Marian AJ
    Curr Opin Cardiol; 2010 May; 25(3):222-8. PubMed ID: 20124997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy.
    Paulin FL; Hodgkinson KA; MacLaughlan S; Stuckless SN; Templeton C; Shah S; Bremner H; Roberts JD; Young TL; Parfrey PS; Connors SP
    Heart Rhythm; 2020 Jul; 17(7):1159-1166. PubMed ID: 32120009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The
    Orgil BO; Munkhsaikhan U; Pierre JF; Li N; Xu F; Alberson NR; Johnson JN; Wetzel GT; Boukens BJD; Lu L; Towbin JA; Purevjav E
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H866-H880. PubMed ID: 37083466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
    Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy.
    Christensen AH; Andersen CB; Tybjaerg-Hansen A; Haunso S; Svendsen JH
    Clin Genet; 2011 Sep; 80(3):256-64. PubMed ID: 21214875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
    El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
    Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal arrhythmogenic right ventricular cardiomyopathy with double mutations in TMEM43.
    Honda T; Kanai Y; Ohno S; Ando H; Honda M; Niwano S; Ishii M
    Pediatr Int; 2016 May; 58(5):409-411. PubMed ID: 26840987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
    Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
    J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
    Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
    Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-Kinase Inhibition During Early Cardiac Development Causes Arrhythmogenic Right Ventricular Cardiomyopathy in Mice.
    Ellawindy A; Satoh K; Sunamura S; Kikuchi N; Suzuki K; Minami T; Ikeda S; Tanaka S; Shimizu T; Enkhjargal B; Miyata S; Taguchi Y; Handoh T; Kobayashi K; Kobayashi K; Nakayama K; Miura M; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2172-84. PubMed ID: 26315406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.
    Rouhi L; Cheedipudi SM; Chen SN; Fan S; Lombardi R; Chen X; Coarfa C; Robertson MJ; Gurha P; Marian AJ
    Cardiovasc Res; 2021 Sep; 117(11):2377-2394. PubMed ID: 33070193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.